ZLB Bioplasma AG
Records under this name other than patents ZLB Bioplasma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,491,693 | HDL for the treatment of stroke and other ischemic conditions Formerly held Term ended Term ended Nov 22, 2022 · USPTO record | Term ended | Term ended Nov 22, 2022 | USPTO record |
| US 7,053,049 | Method for treating unstable angina pectoris Formerly held Term ended Term ended Apr 1, 2022 · USPTO record | Term ended | Term ended Apr 1, 2022 | USPTO record |
| US 6,407,212 | Method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions Formerly held Term ended Term ended Jul 28, 2020 · USPTO record | Term ended | Term ended Jul 28, 2020 | USPTO record |
| US 7,038,020 | Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use Formerly held Term ended Term ended Jun 20, 2017 · USPTO record | Term ended | Term ended Jun 20, 2017 | USPTO record |
| US 7,429,647 | Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use Term ended Term ended Jun 20, 2017 · USPTO record | Term ended | Term ended Jun 20, 2017 | USPTO record |
| US 6,136,312 | Method for producing an IgM preparation for intravenous application Lapsed on the fee record Ended Oct 24, 2004 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2004 | USPTO record |
| US 5,089,602 | Process for the manufacture of apolipoproteins from human blood plasma or serum Term ended Term ended no later than Feb 18, 2012 · Low confidence | Term ended | Term ended no later than Feb 18, 2012 | Low confidence |
| US 5,593,675 | Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation Formerly held Term ended Term ended no later than Jan 14, 2017 · Low confidence | Term ended | Term ended no later than Jan 14, 2017 | Low confidence |
| US 5,652,339 | Method of producing reconstituted lipoproteins Formerly held Term ended Term ended no later than Jul 29, 2017 · Low confidence | Term ended | Term ended no later than Jul 29, 2017 | Low confidence |
| US 5,696,236 | Method for the removal of viruses from protein solutions Term ended Term ended no later than Dec 9, 2017 · Low confidence | Term ended | Term ended no later than Dec 9, 2017 | Low confidence |